MCRN as a collaborative research group had been in existence for over a decade prior to 2016. In 2016, this collaboration was formalized into a non-for-profit national research organization with the purpose of developing infrastructure to streamline Myeloma research activity nationally, thereby accelerating cure. Since its formation, MCRN has been collaborating with a number of pharmaceutical companies to bring industry clinical trials for Myeloma into Canada, design and administer its own trials that allow participation of hundreds of patients nationally. MCRN’s research activities are amplified by the creation of the a national database platform, which positions MCRN as one of the leaders in Real World Data (RWD) research in Multiple Myeloma and Related Diseases. MCRN’s bench to bedside research strategy is complete by the creation of its correlative research platform, which is supported by MCRN National Myeloma Biobank and the Database.
MCRN operations office located in the greater Toronto area (GTA) provides infrastructure and expertise in clinical research development and administration across Canada.
MCRN brings together the academic researchers, industry partners and patientsto design research that prioritizes the patient need
MCRN research activities include Clinical Trials, Real World Data Research (MCRN Database) and Correlative Research platforms (MCRN Bio Bank).
The Myeloma Canada Research Network (MCRN) is comprised of a dedicated pan-Canadian group of scientists, investigators, and clinicians representing 20 centers in nine provinces. They share a common vision: to work together towards a world where Myeloma is no longer a fatal disease. The MCRN Board of Directors bring a range of expertise and knowledge to the task, and work in close collaboration with Myeloma Community at large to achieve it goals.
Dr White is a hematologist, professor of medicine, and senior associate dean of education at Dalhousie Medical School. He has a long-standing interest in medical educationread more
Dr Song trained in Hematology and then as a Leukemia/Bone Marrow Transplant Fellow in Vancouver from 1998-2000. He did further bone marrow transplant trainingread more
A native of Winnipeg, Manitoba, Ms Manchulenko graduated with a Bachelor of Nursing degree from the University of Manitoba in 2001. While working as a clinical researchread more
Dr Reece is Professor of Medicine at the University of Toronto and Director of the Program for Multiple Myeloma and Related Diseases in the Department of Medicalread more
Lorelei has been very active in the myeloma community for seven years. Lorelei has held various roles in the Myeloma Alberta Support Society, including President for three years,read more
Dr Venner completed his medical training at the University of Calgary and later attended the University of British Columbia to complete a specialty degree in Hematology.read more
Mr. Gul is Director of Research & Operations and the treasurer at Myeloma Canada Research Network (MCRN), a not-for-profit organization that develops and administers clinical research in Multipleread more
Director of Research & Operations
Clinical trial specialist
Data Manager/In-house Monitor